American Opinion: How to cut US drug prices without hurting innovation

American Opinion: How to cut US drug prices without hurting innovation

The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S. ; in Germany , it’s $328. The U.S. price for Keytruda, a cancer treatment, is $191,000 a year; in Japan , it’s $44,000. The U.S. pays three times more for branded prescription drugs, on average, than other rich countries. It certainly looks as though Americans are getting a bad deal. The White House wants to narrow this discrepancy. Recently, health o…

From PRI's Right by the Bay Blog: To Improve Drug Affordability Congress Should Fix the Payment System - Center for Medical Economics and Innovation

To Improve Drug Affordability Congress Should Fix the Payment System President Trump has issued an Executive Order (EO) demanding that drug prices in the U.S. equal the lowest price among comparable industrialized countries. This EO fails to understand the complex drug payment system and threatens to harm patients. Demanding that drug prices in the U.S. equal overseas prices is akin to demanding that the price of all expensive handbags should eq…